IN whooping-cough, immunity, once acquired, usually lasts a lifetime. Second attacks of the disease have been reported but are rare. If each occurrence of a second attack was confirmed by cough plate culture or by complement fixation, the number of genuine second attacks would be even less.
Where a bacterial infection confers a lifelong immunity we expect to obtain good results from prophylactic inoculation. Vaccine therapy in whooping-cough has had its ups and downs since it was introduced by Bordet in 1909, but it has steadily gained favour as a prophylactic.
It is to be regretted that no field experiments have been carried out in this country on a sufficiently large scale, whereby our laboratory work could be led to its natural conclusion.
Up to 1930, most stock pertussis vaccines were made from old laboratory strains of H. pertussis, rough from cultivation on unsuitable medium. Leslie and Gardner (1931) described the S -* R variation which takes place when strains of H. pert ussis are grown for long periods on laboratory medium. In my experience, all newly isolated strains have smooth colonies and are fully virulent. These are the Phase I strains of Leslie and Gardner, who traced the degeneration of their newly isolated strains through various phases until they eventually reached Phase IV, the permanently rough state. Only Phase I strains were proved to be fully virulent in animal experiments. Antisera made against Phase I strains will completely agglutinate only Phase I organisms. Strains in the intermediate phases partly agglutinate with Phase I antiserum, but fully agglutinate against their homologous phase antiserum. Phase IV serum agglutinates only rough or avirulent strains.
Pertussis vaccine should be made only from strains which are in Phase I, and which are either newly isolated, or have been maintained in Phase I by growth on Bordet-Gengou medium. This brings it into line with other vaccines used in prophylaxis which are made only from strains of proved pathogenicity and potency. Vaccines are best made from cultures grown on media containing human blood. It is inadvisable to use animal blood, because the percentage of blood necessary to provide a good medium is so great that there is a danger of rendering the vaccinated person hypersensitive to the animal protein contained in the serum, and consequently in the vaccine also. This danger is particularly great if the subjects are children under 1 year of age, who may receive, under some schemes of dosage, as much as 8 c.c. of the vaccine during the course of immunization. Lawson (1939) has confirmed the observation of Leslie and Gardner that only Phase I, or smooth vaccines, are capable of protecting mice. The following table has been adapted from Lawson's paper:- Krueger. et al., 1933. Thus the " S " vaccine gave nearly ten times as much protection as the " R " vaccine, while, in this experiment, undenatured bacterial antigen gave no protection.
Most of the recent work on the prophylaxis of whooping-cough has been done with vaccines made from strains of Phase I. The literature of the last nine years contains records of some twenty thousand children who have been inoculated against pertussis, and the attack rate in most cases was under 5%. About one-tenth of those inoculated are suspected of having intimate contact with the disease subsequent to the completion of their immunization course. The communicability rate is the percentage of the exposed children who eventually contract the disease. It shows an approximate average in the inoculated children of 10%, comparedwith a communicability rate in controls from 60 to 90%, according to the severity of the epidemic.
It is perhaps significant that the communicability rate in both inoculated and control groups rises steadily with the intimacy of contact and exposure, showing that artificially acquired immunity, like the natural immunity, is only relative. Inoculation greatly modifies the course of the disease, and all but a small percentage of cases in the inoculated group are classified as mild or atypical. Many of the cases appearing in the inoculated groups would not have been identified as whooping-cough had there not been a most rigid follow-up system. These results compare very favourably with those reported recently from the use of vaccines in prophylaxis against B. typhosus and the meningococcus.
In Table II some of the more important results of field experiment in U.S.A. and Canada and elsewhere are recorded. The list is by no means complete, because of the difficulty in comparing the results of so many different workers, but it includes the successes as well as some of the reported failures. t Madsen worked during an epidemic, so that most of his cases were exposed to infection before immunity had time to develop. His figures are reallv in support of attempting immunization during the incubation period. + All children who were exposed to infection within one month of the first dose of vaccine have been excluded from this table.
When failures of immunization are reported in vaccinated children it should be remembered that there are many spasmodic coughs simulating whooping-cough, 20 Section of Therapeutics and Pharmacology and there should be bacteriological control in a suspected case. A correct clinical diagnosis of whooping-cough is important, but frequently this is lacking. All the reports of past experiments show the necessity for a reliable bacteriological guide to control the diagnosis, and this can only be found in the cough plate method. In a recent epidemic in 1937 I found that the cough plate gave a positive method of diagnosis in approximately 90% of cases during the catarrhal stage, and the first week of the disease. Thereafter the percentage of positive cultures dropped steadily until in the third week not more than 50% were positive. It requires some practice to become proficient in this method of diagnosis, but with.care, any bacteriologist can become efficient in from two to three months.
In the western districts of London a year has elapsed since notification was made compulsory, and the opportunity was afforded of correlating the clinical diagnosis of the. general practitioners, welfare centres, schools and general hospitals, with bacteriological diagnosis by the cough plate method. This revealed that more than half of the cases notified as cases of whooping-cough and referred to the clinic were not infected by H. pertussis.
In addition to its diagnostic value, the cough plate has given us confirmation of Leslie and Gardner's work on the phases of H. pertussis, and has drawn our attention to what may be a new disease, namely, parapertussis.
The Function of the Clinic When in 1934 I first became responsible for preparing pertussis vaccine on a, large scale, I found it necessary to start a diagnostic clinic, in order to ensure a constant supply of fresh strains. This clinic was soon extended to embrace treatment, and later prophylaxis, of the disease. The inoculation of the brothers and sisters of our patients, as well as some of those who had been in contact with them, either at school or at the welfare centre, provided us with a ready means of testing the potency of our vaccine. Most of the inoculations, therefore, took place during the incubation period and during constant exposure, and this was a very severe test for the vaccine. Although prevention was apparently secured in only about 25% of child contacts, we were able to modify the severity of the disease in perhaps another 50%. These results agree with those of Madsen in 1929 (Table II) , who attempted immunization during a fierce epidemic in the Faroe Islands. Since by our system of dosage it was impossible for the inoculated children who contracted the disease within one month from the commencement of the course to have acquired immunity, I have not included this group in my records.
The Choice of Antigen Generally speaking, no chemically altered vaccine is as good as the simple suspensions of killed bacteria, and pertussis vaccine is no exception. A simple suspension of killed Phase I strains is the only antigen which has so far proved of value in recent field experiments. j However, such a huge dosage has been demanded by most clinicians that a constant search has been made for something better, and many attempts have been made to modify the vaccine.
It has been argued that if the antigens were in solution they must be more effective, and attempts were made to find a soluble pertussis antigen which would be more quickly assimilated into the body. Phase I strains of H. pertussis elaborate a toxic substance which is not a true exotoxin in that it is not antigenic. This toxic substance, and most other chemical extracts or fractions of the organism, are 21 427 unstable and easily destroyed during their preparation, and so are incapable of producing a solid immunity. This, of course, does not apply to the F.68 fraction of Cruickshanks and Freeman (1937) which was apparently fully antigenic, and very stable in the dry form. Undenatured bacterial antigen, Krueger (1933) , at first had a very great following, but it has been shown by Lawson experimentally, and by Singer-Brooks clinically, to have no value as a prophylactic. It will be recalled that the antigens in diphtheria toxoid, originally prepared in kolution, are now deliberately precipitated by alum to make them more effective. Harrison, Franklin and Bell (1938) have reported favourably on the use of alumprecipitated pertussis vaccine. Following the suggestion of Ledingham (1939) , we combined pertussis vaccine with alum-precipitated diphtheria toxoid, and found that in this combination the vaccine contained a good antigen, and stimulated the production of both agglutinins and protective substances in mice.
The Dosage of Pertussis Vaccine for Maximum Immunity
The optimal dose of pertussis vaccine for prophylaxis has not yet been settled. In America, the common dosage given in a course of from two to four weeks is 80,000 million organisms. Sauer started with a dose of 22,000 million bacteria, but rapidly increased it to 80,000 million. So impressive are his results that all other American workers appear to have followed him, and strictly adhered to his course of immunization. Kendrick and Eldering (1939) , in the biggest and best field experiment yet recorded, chose a dose of 70,000 million bacteria. Silverthorne, in Canada, has given up to 120,000 millions. I cannot believe that a dose of 120,000 millions is necessary for the immunization of a child under year of age. The vaccine is not at fault; it is the method of application, in relation to the induction of immunity, which has not received due consideration.
Since individuals differ enormously in their powers to immunize themselves, there is no prophylactic method of immunization which can guarantee protection in all cases. In young children especially, it is desirable to choose doses of vaccines producing a good immunizing response without unreasonable discomfort to the patient. Various doses will give good protection, but the mere quantitative increase of any dose will not substantially raise the percentage of children protected.
Sauer states that immunity takes from two to three months to develop. This is a great handicap during an epidemic. Such large doses as are recommended by Sauer put too heavy a strain on the process of immunization in the young child, and immunity is delayed. In prophylactic inoculation the primary dose need not be more than that amount necessary to initiate the child's immunizing mechanism, and prepare it to respond quickly to a later stimulus, either the actual infection or another dose of vaccine. When response to the primary dose has been shown by the production of antibodies, the process of immunizing can then be carried further. Park (1936) has shown the effect of different doses from 1,000 million up to 88,000 million, and these are given in a modified table (Table IV ). An attack rate of only 3% was obtained with doses of 1 to 15,000 million, but an attack rate of 1% was still shown when doses of 66 to 88,000 million were given.. Kendrick (1939) also mentions that a small number of children who had received only 4 c.c. of vaccine had an incidence of 2-8 per 100 person years, while those who received the whole course of 7 c.c. had an incidence of 2-3: These figures confirm our statement that there is not sufficient evidence in favour of the very large dose.
Effective prophylaxis consists in a primary stimulus followed by a secondary stimulus after an appropriate interval. In antityphoid vaccination, which has proved very effective, the interval between the first and second doses is only ten days, but with antigens such as diphtheria toxoid or tetanus toxoid the most effective interval between the primary and secondary stimulus is one month or longer. Toxoids are slow immunizers. Similarly, pertussis vaccine is a slow immunizer, and doses must not be given too close to one another. It is far better to allow an interval of one month before continuing with stimulating doses. The system adopted in America of increasing the dose after every clinical failure may be of questionable value. With this in view, I have for the last four years at our Clinic at St. Mary's Hospital used the following scheme of dosage Dose 1: 4,000 million with an interval of three to seven days. Dose 2: 4,000 million with an interval of three to seven days. Dose 3: 4,000 million with an interval of at least one month. Dose 4: 4,000 million. In a test group of 513 children with 46 known and 45 suspected exposures not a single-case of whooping-cough occurred. In the control group of 154 children with 115 exposures, 89 cases of the disease developed.
The following case is a striking example of the value of the secondary stimulus even after a long interval.
A young adult who had never had pertussis was inoculated as follows 1937: Five doses each of 4,000 million in the course of twenty-eight days. Maximum titre of agglutination, 1: 250. 1938 : One dose of 4,000 million. 1939: One dose of 1,000 million. Agglutination titre after ten days 1: 10,000.
After the first period of injections there is a fair response, but not comparable to that found after the stimulating dose two years later. With the rise in agglutinins there is also an increase in the protective substances in the serum, which has been demonstrated experimentally in mice. This method of giving a final dose after a 
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considerable interval to induce a satisfactory secondary response has not previously been used in pertussis prophylaxis. This secondary response has also been noticed by Wu and Chu (1938) , and Miller and Silverberg (1939) ; but they have not employed this method deliberately in the immunizing process. Most of our immunization had to be carried out when our patients were exposed to infection; time, therefore, was always an important factor, and the month gained by our course was important.
The American workers, however, commenced immunization at a fixed age in welfare centres. Our system at St. Mary's Hospital provides for smaller doses which please both parent and child, and this demonstrates that if an inoculated child is exposed to infection there is plentv of time to call forth a secondary response of immunity during the incubation period.
In reviewing the results of prophylactic inoculation for pertussis we find that if immunity breaks down at all, this usually occurs during the second year of life, when the child starts to mix with others, and so greatly increases the chance of picking up infection. If, however, another suitable inoculation can be given at this period, immunity is at once stimulated and often rises far higher than at any time during the first course of immunization. Moreover, if a child who has been so " prepared " by inoculation to respond rapidly is exposed to infection at some period there is plenty of time during the incubation period to call forth a response to a fresh dose of vaccine. From Table II it will be seen that in a large proportion of exposures the infection itself is sufficient to stimulate a sufficient response in the " prepared " child to save it from an attack of whooping-cough. However, when it is essential to avoid an attack of the disease, Ino harm, but possibly much good, will result from giving a stimulating dose of 4,000 million pertussis vaccine.
Age and Immmunization
Children born into a household where there is a case of whooping-cough are liable to contract the disease during the first month of life. The youngest case of typical whooping-cough that occurred within the scope of the clinic was 3 weeks old. Newborn children have been immunized by vaccines, but it should not be lightly undertaken. Madsen (1933) has reported two cases of death following inoculation with pertussis vaccine in newborn children. Our experience is that the best method of prevention in very young children is to isolate them from the infected members of the household by placing them under a muslin covering, and if exposure is known to have taken place, to attempt passive immunization by the use of convalescent serum. By adopting these measures several children born under these circumstances have been protected from the disease.
The immunization of children under 6 months of age against any disease, except perhaps against vaceinia, is difficult to attain. The response to pertussis vaccine is usually slow and incomplete, and our experience has shown that the earliest age at which immunization can be successfully attempted is between 6 and 12 months. Children of this age may safely be given the full scale of dosage, and from this period until 7 -or 8 years of age they respond well, and are easily immunized. To save repeated inoculations young children may be simultaneously immunized against whooping-cough and diphtheria. The response to both antigens is equally good, and at least as good as when each antigen is given separately. In these children the reactions to pertussis vaccine are negligible and can be ignored.
The only contra-indications to the immunization of very young children are debility caused by other diseases, or malnutrition. Children immunized in late childhood make a good immunity response, but the reaction to the vaccine in this Section of Therapeutcs and Pharmacology 431 group is much more marked, and often delays the immunization course. In the few adults who have been given a full, course of pertussis vaccine the reactions were generally severe and painful. Immunization may safely be undertaken during epidemic periods, though, of course, this is not the best time to choose. Madsen prefers to wait until an epidemic starts before carrying out universal inoculation but he is practically alone in advising this procedure.
Duration of Immunity
Immunity in whooping-cough, both naturally and artificially acquired, is generally considered to be lifelong, but there are cases of apparently genuine second attacks. These second attacks occur where the exposure is intimate and prolonged, as in families, orphanages, and other institutions, where there also is a large percentage of non-immune individuals. Seigel and Goldberger (1937) have demonstrated that many mild and atypical cases of whooping-cough have occurred in these circumstances in children with a previous history of the disease. They reported that the incidence and severity of whooping-cough were the same in those who had had previous attacks as in the inoculated children when exposed to the disease. It is not surprising, therefore, that artificially acquired immunity as produced by vaccine also broke down. However, in both these groups the disease was much milder than that seen in the control non-immune groups. Thus, in the face of exaggerated exposure, immunity can only be relative.
Prophylactic immunity may be expected to protect over 90% of the children inoculated, and from the point of view of the Public Health authority this will be satisfactory. The general practitioner will also find prophylactic immunization worth while, but in his own interest and that of the child, he will find it advisable to be prepared to give a further dose of vaccine if the child is exposed to infection.
The long incubation period of the disease allows the child to .reinforce his immunity after the additional dose of vaccine and so prevent an infection.
SUMMARY
The best age to start immunization is during the first or second years of the child's life. Among the inoculated children the attack rate is less than 5%, and the communicability rate is less than 10% as against 60-90% in the control groups.
The primary immunizing dose of vaccine need only be sufficient to establish a sound basal immunity. Once this basal immunity has been established the immunity can easily be stimulated by subsequent doses of vaccine, which act in the nature of a " secondary response ". By using this " secondary response " and a total dosage of only 16,000 million organisms, apparently good immunity was attained. In a test group of 513 children with 46 known exposures and 45 suspected exposures not a single case of whooping-cough occurred. In a control group of 154 exposures 89 cases of the disease occurred.
